Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device

Bibliographic Details
Main Authors:	Michele Murphy, MD, Timothy Welch, MD, Peter W. Shaw, MD, Jamie L.W. Kennedy, MD, Kenneth C. Bilchick, MD, MS, FHRS
Format:	Article
Language:	English
Published:	Elsevier 2016-11-01
Series:	HeartRhythm Case Reports
Subjects:	Ventricular assist devices Implantable cardioverter-defibrillator Pacemaker Cardiac resynchronization therapy Electromagnetic interference Bradycardia Ventricular tachycardia
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214027116300616

Similar Items

Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator
by: Naomichi Matsumoto, MD, et al.
Published: (2010-01-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
by: Jun Kishihara, MD, et al.
Published: (2016-02-01)

Prophylactic catheter ablation for ventricular tachycardia reduces morbidity and mortality in patients with implantable cardioverter–defibrillator devices
by: Shinichi Niwano, et al.
Published: (2013-12-01)

A Tragic Case of Wearable Cardioverter-Defibrillator Failure
by: Ariel Vinas, MD, et al.
Published: (2021-02-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
by: Bruce L. Wilkoff, MD, FHRS, CCDS, et al.
Published: (2016-02-01)

Undetected ventricular fibrillation in a single-chamber implantable cardioverter-defibrillator: When the far-field channel sees more than the intraventricular channel
by: Milena Kubickova, MD, et al.
Published: (2016-07-01)

Ventricular Tachycardia Precipitated by Short-long-short Sequence in a Patient with Implantable-cardioverter Defibrillator
by: Diego Chemello, MD, et al.
Published: (2012-01-01)

Right ventricular lead proarrhythmia: A novel intervention for an under-recognized phenomenon
by: Justin Hayase, MD, et al.
Published: (2018-02-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Triple atrial sensing during cardiac resynchronization
by: S. Serge Barold, et al.
Published: (2020-02-01)

Usefulness of a wearable cardioverter defibrillator combined with catheter ablation for ventricular tachyarrhythmia storms after a myocardial infarction: A case report
by: Yusuke Yoshikawa, MD, et al.
Published: (2015-08-01)

First direct human evidence of a probable implantable cardioverter-defibrillator lead-related scar serving as a substrate for ventricular tachycardia
by: Pal Abraham, MD, et al.
Published: (2015-01-01)

Implanted pacemaker and cardioverter-defibrillator in a patient with ectopia cordis
by: Tam Dan N. Pham, MD, et al.
Published: (2020-02-01)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
by: Fabrizio Guarracini, et al.
Published: (2023-07-01)

T-wave oversensing during left ventricular pacing causing inappropriate defibrillation
by: Joshua Payne, MD, MPH, et al.
Published: (2017-10-01)

Clinical impact of applying strategic programming in patients with implantable cardioverter-defibrillators beyond reducing inappropriate shocks
by: You Mi Hwang, et al.
Published: (2020-03-01)

Ineffective implantable cardioverter-defibrillator shocks among patients on continuous left ventricular assist device support: Clinical characteristics and management
by: Malik Shehadeh, MD, et al.
Published: (2020-12-01)

A case of supraventricular tachycardia misdiagnosis after dual‐chamber implantable cardioverter defibrillator implantation with His bundle pacing
by: Xianchao Sun, et al.
Published: (2023-05-01)

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

Influence of myopotential interference on the Wavelet discrimination algorithm in implantable cardioverter-defibrillator
by: Kazuya Mizukami, MD, PhD, et al.
Published: (2017-06-01)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
by: Yoshimori An, MD, et al.
Published: (2017-02-01)

Prospective Randomized Evaluation of Implantable Cardioverter‐Defibrillator Programming in Patients With a Left Ventricular Assist Device
by: Travis D. Richardson, et al.
Published: (2018-03-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Elective implantable cardioverter-defibrillator removal with extraction of leads following catheter ablation of idiopathic ventricular fibrillation and long-term surveillance
by: Norman C. Wang, MD, MS, FHRS, et al.
Published: (2020-07-01)

Surgical and electrophysiological considerations in the management of a patient with a subcutaneous implantable cardioverter-defibrillator undergoing coronary artery bypass surgery
by: Brett Angel, MD, et al.
Published: (2017-01-01)

Prevention of Early Sudden Cardiac Death after Myocardial Infarction Using the Wearable Cardioverter Defibrillator—Results from a Real-World Cohort
by: Ursula Rohrer, et al.
Published: (2023-07-01)

Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry
by: Ibrahim El‐Battrawy, et al.
Published: (2023-09-01)

Implantable cardioverter defibrillator in MC Ljubljana. An overview from 1989–2005
by: Igor Zupan, et al.
Published: (2005-12-01)

Prophylactic catheter ablation of ventricular tachycardia before cardioverter-defibrillator implantation in patients with non-ischemic cardiomyopathy: Clinical outcomes after a single endocardial ablation
by: Atsushi Suzuki, MD, et al.
Published: (2015-06-01)

Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience
by: Gabriela M. Orgeron, et al.
Published: (2018-11-01)

Reuse Potential of Pacemakers and Implantable Cardioverter-defibrillators - Some Real World Data
by: S.P. Abhilash, et al.
Published: (2013-05-01)

The Automatic External Cardioverter-Defibrillator
by: Antoni Martínez-Rubio, et al.
Published: (2004-07-01)

Polymorphic ventricular tachycardia due to change in pacemaker programming
by: Ihab Elsokkari, MBBCh, MMed, FRACP, et al.
Published: (2017-05-01)

Implantable cardioverter defibrillators in the prevention of sudden cardiac death
by: L A Bockeria, et al.
Published: (2017-12-01)

Wearable cardioverter defibrillator for preventing sudden cardiac death in patients at risk: An updated systematic review of comparative effectiveness and safety
by: Gregor Goetz, et al.
Published: (2023-04-01)

CHA2DS2-VASC score predicts coronary artery disease progression and mortality after ventricular arrhythmia in patients with implantable cardioverter-defibrillator
by: Refik Kavsur, et al.
Published: (2021-06-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

Identification and management of right ventricular perforation using pacemaker and cardioverter-defibrillator leads: A case series and mini review
by: Mohammad Ali Akbarzadeh, MD, et al.
Published: (2017-02-01)